Insider Transactions in Q2 2024 at Treace Medical Concepts, Inc. (TMCI)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 11
2024
|
John T. Treace Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
45,000
+0.7%
|
$225,000
$5.88 P/Share
|
|
May 31
2024
|
James T Treace |
BUY
Open market or private purchase
|
Direct |
25,000
+2.15%
|
$150,000
$6.05 P/Share
|
|
May 29
2024
|
James T Treace |
BUY
Open market or private purchase
|
Direct |
25,000
+2.19%
|
$125,000
$5.2 P/Share
|
|
May 28
2024
|
James T Treace |
BUY
Open market or private purchase
|
Direct |
50,000
+4.39%
|
$250,000
$5.07 P/Share
|
|
May 24
2024
|
Richard W Mott |
BUY
Open market or private purchase
|
Direct |
18,000
+1.65%
|
$90,000
$5.19 P/Share
|
|
May 22
2024
|
Richard W Mott |
BUY
Open market or private purchase
|
Direct |
12,100
+1.13%
|
$48,400
$4.99 P/Share
|
|
May 21
2024
|
Lawrence W Hamilton |
BUY
Grant, award, or other acquisition
|
Direct |
15,091
+42.84%
|
-
|
|
May 21
2024
|
Betsy Hanna |
BUY
Grant, award, or other acquisition
|
Direct |
15,091
+41.44%
|
-
|
|
May 21
2024
|
Lance A Berry |
BUY
Grant, award, or other acquisition
|
Direct |
15,091
+42.19%
|
-
|
|
May 21
2024
|
John K Bakewell |
BUY
Grant, award, or other acquisition
|
Direct |
15,091
+9.13%
|
-
|
|
May 21
2024
|
Deepti Jain |
BUY
Grant, award, or other acquisition
|
Direct |
15,091
+24.57%
|
-
|
|
May 21
2024
|
Jane E Kiernan |
BUY
Grant, award, or other acquisition
|
Direct |
15,091
+27.38%
|
-
|
|
May 21
2024
|
Richard W Mott |
BUY
Grant, award, or other acquisition
|
Direct |
15,091
+1.43%
|
-
|
|
May 17
2024
|
John T. Treace Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
100,000
+1.55%
|
$500,000
$5.56 P/Share
|
|
May 14
2024
|
Jane E Kiernan |
BUY
Open market or private purchase
|
Direct |
19,356
+43.7%
|
$96,780
$5.17 P/Share
|
|
May 14
2024
|
John T. Treace Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
150,000
+2.35%
|
$750,000
$5.12 P/Share
|
|
May 13
2024
|
James T Treace |
BUY
Open market or private purchase
|
Direct |
145,000
+12.24%
|
$580,000
$4.54 P/Share
|
|
May 13
2024
|
Richard W Mott |
BUY
Open market or private purchase
|
Direct |
36,802
+3.46%
|
$147,208
$4.38 P/Share
|
|
May 13
2024
|
John T. Treace Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
150,000
+2.4%
|
$600,000
$4.56 P/Share
|
|
May 10
2024
|
Deepti Jain |
BUY
Open market or private purchase
|
Direct |
25,000
+44.46%
|
$100,000
$4.5 P/Share
|
|
May 10
2024
|
James T Treace |
BUY
Open market or private purchase
|
Direct |
83,000
+8.49%
|
$332,000
$4.53 P/Share
|
|
May 10
2024
|
Richard W Mott |
BUY
Open market or private purchase
|
Direct |
83,198
+7.75%
|
$332,792
$4.57 P/Share
|
|
May 10
2024
|
John K Bakewell |
BUY
Open market or private purchase
|
Direct |
130,000
+49.05%
|
$520,000
$4.57 P/Share
|
|
May 10
2024
|
John T. Treace Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
150,000
+2.46%
|
$600,000
$4.58 P/Share
|